TrialThe New England journal of medicine2019
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
677 papers cite itlatest 60 shown
this paperpooled ittrialcites it